Clinical Research

A Look At Current and Future Screening Biomarkers Excerpts from Clinical Lab News Volume 38, No.8, Aug. 2012 By Leticia M. Acosta, CLS-Biochem., MS According to the American Cancer society, prostate cancer (PCa) is the second most common type of cancer found in American men and the second leading cause of cancer death after lung

AARP BULLETIN: Dated JULY – AUG. 2012, VOL.53, NO.6Excerpts by Eloisa Dominguez Our waistline is a good indicator of visceral fat. According to scientist there are two different kinds of fat. Subcutaneous fat, the kind that you can pinch and visceral fat or belly fat which is deep inside the body that surrounds the abdominal

Medical Laboratory Observer, May 2013 Vol. 45 No. 5Excerpts by Connie Cailer Vitamin D has become one of the most widely discussed and intensely scrutinized supplements in recent history. The renewed interest is due to the startling prevalence of vitamin D deficiency worldwide and linking this to multiple clinical conditions other than bone health. Vitamin

Clinical Laboratory News, March 2013Excerpts by: Leticia M. Acosta, M.S. The American Cancer Society estimates that 22,280 new cases and 15,500 deaths from ovarian cancer occurred in the U.S. in 2012. The disease is the leading cause of death from gynecological cancers, as well as the fifth-leading cause of cancer deaths in women. Unlike breast

Definition: Fecal microbiota transplantation or FMT is the transfer of fecal material containing bacteria and natural anti-bacterials from a healthy individual into a diseased recipient. Previous terms for the procedure include fecal bacteriotherapy, fecal transfusion, fecal transplant, stool transplant, fecal enema, and human probiotic infusion (HPI). Because the procedure involves the complete restoration of the

Next generation technologies (NGT) deliver huge improvements in cost efficiency, accuracy, robustness, and in the amount of information they provide. Microarrays, high throughput sequencing platforms, digital droplet PCR, and other technologies all offer unique combinations of desirable performance. As stronger evidence of genetic testing’s clinical utility influences patterns of patient care, demand for NGT testing